Back to News
Market Impact: 0.12
PB125® Enhanced Vascular Function in Older Adults and Preserved Vascular Function During Disuse in Human Clinical Study
Source: PRWeb
Healthcare & Biotech
Pathways Bioscience announced publication of a randomized, double-blind, placebo-controlled human clinical study evaluating PB125. The company said the study provides evidence supporting PB125's role in Nrf2 activation, vascular health and antioxidant defenses, but the excerpt disclosed no efficacy statistics, patient counts or financial implications.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
More News
- Wall Street Week | China’s Trade Reckoning, Syracuse’s Second Chance, Humanoids in Healthcare
- Yields keep rising, Novo's tough week, why cat product sales are surging and more in Morning Squawk
- Details on U.S.-China trade negotiations coming Monday, USTR Greer says
- At Meta Connect, the company’s smart glasses were everywhere
- ShinyHunters tells The Reg: We hacked the FBI to 'protect our business'
- For months, OpenAI’s agent swarms have been attacking online databases to find obscure facts